Dr. Sun is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
875 Blake Wilbur Dr
Palo Alto, CA 94304
Summary
- Dr. Fangdi Sun is an oncologist based in Palo Alto, CA. She completed her residency and chief residency in internal medicine at the University of California, San Francisco after graduating from Harvard Medical School. Prior to her medical education, she studied Biological Engineering at the Massachusetts Institute of Technology. Currently, she is a fellow in Hematology and Medical Oncology at Stanford University, with a focus in thoracic / head & neck malignancies. Her publications, which have been cited numerous times by other works, range from research on specific treatments for lung cancer to the evaluation of care protocols during the COVID-19 pandemic.
Education & Training
- University of California (San Francisco)Residency, Internal Medicine, 2018 - 2021
- Harvard Medical SchoolClass of 2018, MD
- Massachusetts Institute of TechnologyBS, Biological Engineering, Tau Beta Pi, Phi Beta Kappa, 2010 - 2014
Certifications & Licensure
- CA State Medical License 2019 - 2025
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator's Consortium Registry Analysis.Margaret Stalker, Connor B Grady, Alex Watts, Wei-Ting Hwang, Krishna Chandrasekhara
JTO Clinical and Research Reports. 2025-01-01 - Targeting the EZH2-SLFN11 pathway-a lesson in developing molecularly-informed treatments for recurrent small cell lung cancer.Fangdi Sun, Millie S Das
Translational Cancer Research. 2024-12-31 - Determining Line of Therapy from Real-World Data in Non-Small Cell Lung Cancer.Connor B Grady, Wei-Ting Hwang, Joshua E Reuss, Wade Iams, Amanda Cass
Pharmacoepidemiology and Drug Safety. 2024-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: